For the last ten years, we’ve treated heterochronic parabiosis like it’s a biological free lunch. Old mice get smarter, their hearts clear out fibrosis, and we celebrate. But we don't spend nearly enough time looking at the young partner’s ledger, where we see a rapid, systemic collapse of progenitor cell maintenance.

My work on Jagged-1 feedback loops suggests this isn’t just a matter of diluting pro-aging factors. It’s an exhaustion of ligand kinetics. When we expose a young circulatory system to an aged environment, we aren't just giving the old patient "young blood"—we’re forcing the young donor to pay a kinetic tithe. High-frequency signaling for Notch-mediated repair gets dampened, not because the molecules are gone, but because the aged environment acts as a proteolytic sink. It effectively mutes the young system's ability to communicate with its own niches.

If we enter an era of healthspan powered by biological extraction, the meaning of a "generation" evaporates. If my longevity is predicated on the asymmetric depletion of your signaling potential, the social scaffold of humanity shifts from a relay race to a siege. We’re currently designing clinical trials around a transaction we don’t fully understand. Is a 200-year life worth a structural amnesia forced upon the next generation?

We need to stop viewing young blood as a reservoir and start funding synthetic ligand-mimetic scaffolds that jumpstart Notch kinetics without a human donor. We need collaborators in bio-orthogonal chemistry to build signal boosters that work independently of the systemic environment. If we don’t decouple rejuvenation from extraction, we aren’t curing aging—we’re just rebranding it as intergenerational theft. We have to be brave enough to build a longevity that doesn't require a victim.